RxNorm 2059266
        Tiglutik 50 MG in 10 mL Oral Suspension
    
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 2059266 unique identifier include: Tiglutik 50 MG in 10 mL Oral Suspension (12759477), riluzole 5 MG/ML Oral Suspension [Tiglutik] (12357493), Tiglutik 5 MG/ML Oral Suspension (10338813), Tiglutik 50 MG per 10 ML Oral Suspension (10338815) and Tiglutik 25 MG per 5 ML Oral Suspension (10782980).
RxNorm Atom ID: 12759477 - Prescribable Name
 
Tiglutik 50 MG in 10 mL Oral Suspension
 
- RXCUI:
- 2059266 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12759477 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Tiglutik 50 MG in 10 mL Oral Suspension - Description of concept identifier
- Term Type (TTY):
- PSN - Term type in source with name and description
- Term Type Name:
- Prescribable Name - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. - Description of term type in source
- Code:
- 2059266 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N 
 Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
- CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_250902F - The source version
- Source Date:
- September 02, 2025 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
- Source Content Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
- Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 12357493 - Semantic Branded Drug
 
riluzole 5 MG/ML Oral Suspension [Tiglutik]
 
- RXCUI:
- 2059266 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12357493 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- riluzole 5 MG/ML Oral Suspension [Tiglutik] - Description of concept identifier
- Term Type (TTY):
- SBD - Term type in source with name and description
- Term Type Name:
- Semantic Branded Drug - Name of term type in source
- Term Type Description:
- Ingredient + Strength + Dose Form + Brand Name - Description of term type in source
- Code:
- 2059266 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N 
 Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
- CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_250902F - The source version
- Source Date:
- September 02, 2025 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
- Source Content Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
- Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12357493 Attributes
| Property | Value | Explanation | 
|---|---|---|
| RXN AI | {2058144} 35623 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value | 
| RXN AM | {2058144} 35623 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value | 
| RXN AVAILABLE STRENGTH | 5 MG/ML | Available drug strengths listed in the order of ingredients from the drug | 
| RXN BOSS FROM | {2058144} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value | 
| RXN HUMAN DRUG | US | Drug available for use in Humans | 
| RXTERM FORM | Susp | The RxTerm dose form name for this drug | 
RxNorm Atom ID: 10338813 - Synonym
 
Tiglutik 5 MG/ML Oral Suspension
 
- RXCUI:
- 2059266 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10338813 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Tiglutik 5 MG/ML Oral Suspension - Description of concept identifier
- Term Type (TTY):
- SY - Term type in source with name and description
- Term Type Name:
- Synonym - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity. - Description of term type in source
- Code:
- 2059266 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N 
 Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
- CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_250902F - The source version
- Source Date:
- September 02, 2025 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
- Source Content Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
- Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10338815 - Synonym
 
Tiglutik 50 MG per 10 ML Oral Suspension
 
- RXCUI:
- 2059266 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10338815 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Tiglutik 50 MG per 10 ML Oral Suspension - Description of concept identifier
- Term Type (TTY):
- SY - Term type in source with name and description
- Term Type Name:
- Synonym - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity. - Description of term type in source
- Code:
- 2059266 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N 
 Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
- CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_250902F - The source version
- Source Date:
- September 02, 2025 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
- Source Content Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
- Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 10782980 - Synonym
 
Tiglutik 25 MG per 5 ML Oral Suspension
 
- RXCUI:
- 2059266 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 10782980 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Tiglutik 25 MG per 5 ML Oral Suspension - Description of concept identifier
- Term Type (TTY):
- SY - Term type in source with name and description
- Term Type Name:
- Synonym - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity. - Description of term type in source
- Code:
- 2059266 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N 
 Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
- CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_250902F - The source version
- Source Date:
- September 02, 2025 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
- Source Content Contact:
- RxNorm Customer Service
 U.S. National Library of Medicine
 8600 Rockville Pike
 Bethesda
 MD
 United States
 20894
 (888) FIND-NLM
 [email protected]
 https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
- Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Riluzole
Riluzole is used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Riluzole is in a class of medications called benzothiazoles. It works by changing the activity of certain natural substances in the body that affect nerves and muscles.
[Learn More]
* Please review the disclaimer below.